TAS2940, a novel brain-penetrable pan-ERBB inhibitor, for tumors with HER2 and EGFR aberrations. Oguchi K, Araki H, Tsuji S, Nakamura M, et al. Cancer Sci 2023;114:654-664.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oguchi K, Araki H, Tsuji S, Nakamura M, et al. TAS2940, a novel brain-penetrable pan-ERBB inhibitor, for tumors with HER2 and EGFR aberrations. Cancer Sci 2023;114:654-664.
PMID: 36282234